- Home
- NVRI vs CRMD Comparison
NVRI vs CRMD Comparison
Compare NVRI & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVRI
- CRMD
- Stock Information
- Founded
- NVRI 1853
- CRMD 2006
- Country
- NVRI United States
- CRMD United States
- Employees
- NVRI N/A
- CRMD N/A
- Industry
- NVRI Diversified Commercial Services
- CRMD Biotechnology: Pharmaceutical Preparations
- Sector
- NVRI Miscellaneous
- CRMD Health Care
- Exchange
- NVRI Nasdaq
- CRMD Nasdaq
- Market Cap
- NVRI 756.7M
- CRMD 901.8M
- IPO Year
- NVRI N/A
- CRMD 2010
- Fundamental
- Price
- NVRI $11.49
- CRMD $13.93
- Analyst Decision
- NVRI
- CRMD Strong Buy
- Analyst Count
- NVRI 0
- CRMD 7
- Target Price
- NVRI N/A
- CRMD $16.83
- AVG Volume (30 Days)
- NVRI 1.0M
- CRMD 3.3M
- Earning Date
- NVRI 08-05-2025
- CRMD 08-07-2025
- Dividend Yield
- NVRI N/A
- CRMD N/A
- EPS Growth
- NVRI N/A
- CRMD N/A
- EPS
- NVRI N/A
- CRMD 0.79
- Revenue
- NVRI $2,242,873,000.00
- CRMD $121,484,498.00
- Revenue This Year
- NVRI $0.02
- CRMD $404.81
- Revenue Next Year
- NVRI $3.71
- CRMD $56.11
- P/E Ratio
- NVRI N/A
- CRMD $17.46
- Revenue Growth
- NVRI N/A
- CRMD 14970.29
- 52 Week Low
- NVRI $4.72
- CRMD $5.31
- 52 Week High
- NVRI $11.95
- CRMD $17.43
- Technical
- Relative Strength Index (RSI)
- NVRI 77.66
- CRMD 65.99
- Support Level
- NVRI $9.55
- CRMD $12.80
- Resistance Level
- NVRI $11.42
- CRMD $14.44
- Average True Range (ATR)
- NVRI 0.49
- CRMD 0.83
- MACD
- NVRI 0.23
- CRMD 0.23
- Stochastic Oscillator
- NVRI 99.69
- CRMD 86.23
About NVRI Enviri Corporation
Enviri Corp is a market-leading, provider of environmental solutions for industrial and specialty waste streams, and equipment and technology for the rail sector. The company's current operations consist of three divisions: Harsco Environmental, Harsco Rail, and Clean Earth. The company gains its revenue from Harsco Environmental segment. Geographically company operates in USA and International Countries, with majority revenue from USA.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.